Metropolitan Life Insurance Company (MetLife)’s AngioDynamics ANGO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,712	Closed	-$10K	–	142
2024 Q1	$10K	Sell	1,712 -1,055	-38%	-$6.27K	﹤0.01%	2131
2023 Q4	$21.7K	Hold	2,767	–	–	﹤0.01%	1884
2023 Q3	$20.2K	Buy	2,767 +913	+49%	+$7.6K	﹤0.01%	1895
2023 Q2	$19.3K	Hold	1,854	–	–	﹤0.01%	1948
2023 Q1	$19.2K	Sell	1,854 -485	-21%	-$6.21K	﹤0.01%	1903
2022 Q4	$32.2K	Hold	2,339	–	–	﹤0.01%	1747
2022 Q3	$47.9K	Hold	2,339	–	–	﹤0.01%	1486
2022 Q2	$45.3K	Hold	2,339	–	–	﹤0.01%	1569
2022 Q1	$50.4K	Sell	2,339 -7,490	-76%	-$170K	﹤0.01%	1586
2021 Q4	$271K	Hold	9,829	–	–	﹤0.01%	1802
2021 Q3	$255K	Sell	9,829 -1,811	-16%	-$48.4K	﹤0.01%	1900
2021 Q2	$316K	Hold	11,640	–	–	﹤0.01%	1821
2021 Q1	$272K	Hold	11,640	–	–	﹤0.01%	1801
2020 Q4	$178K	Hold	11,640	–	–	﹤0.01%	2008
2020 Q3	$140K	Hold	11,640	–	–	﹤0.01%	2016
2020 Q2	$118K	Hold	11,640	–	–	﹤0.01%	2149
2020 Q1	$121K	Hold	11,640	–	–	﹤0.01%	1910
2019 Q4	$186K	Sell	11,640 -919	-7%	-$14K	﹤0.01%	1975
2019 Q3	$231K	Hold	12,559	–	–	﹤0.01%	1781
2019 Q2	$247K	Hold	12,559	–	–	﹤0.01%	1754
2019 Q1	$287K	Hold	12,559	–	–	0.01%	1660
2018 Q4	$253K	Buy	12,559 +829	+7%	+$17.2K	0.01%	1648
2018 Q3	$255K	Hold	11,730	–	–	﹤0.01%	1839
2018 Q2	$261K	Hold	11,730	–	–	﹤0.01%	1766
2018 Q1	$202K	Hold	11,730	–	–	﹤0.01%	1889
2017 Q4	$195K	Sell	11,730 -13,194	-53%	-$225K	﹤0.01%	1926
2017 Q3	$426K	Hold	24,924	–	–	﹤0.01%	1789
2017 Q2	$404K	Buy	24,924 +4,429	+22%	+$70K	﹤0.01%	1860
2017 Q1	$356K	Hold	20,495	–	–	﹤0.01%	1887
2016 Q4	$346K	Hold	20,495	–	–	﹤0.01%	1991
2016 Q3	$359K	Hold	20,495	–	–	﹤0.01%	1929
2016 Q2	$295K	Hold	20,495	–	–	﹤0.01%	2055
2016 Q1	$252K	Hold	20,495	–	–	﹤0.01%	2034
2015 Q4	$249K	Hold	20,495	–	–	﹤0.01%	2085
2015 Q3	$270K	Buy	20,495 +926	+5%	+$14K	﹤0.01%	2058
2015 Q2	$321K	Sell	19,569 -2,708	-12%	-$45K	﹤0.01%	2069
2015 Q1	$396K	Hold	22,277	–	–	﹤0.01%	1682
2014 Q4	$423K	Buy	22,277 +2,326	+12%	+$39.4K	﹤0.01%	1876
2014 Q3	$274K	Sell	19,951 -2,846	-12%	-$40.6K	﹤0.01%	2147
2014 Q2	$372K	Buy	22,797 +3,358	+17%	+$48.6K	﹤0.01%	2052
2014 Q1	$306K	Sell	19,439 -3,423	-15%	-$55.8K	﹤0.01%	2153
2013 Q4	$393K	Hold	22,862	–	–	﹤0.01%	1982
2013 Q3	$302K	Hold	22,862	–	–	﹤0.01%	2103
2013 Q2	$258K	Buy	+22,862	New	+$243K	﹤0.01%	2155

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ANGO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AngioDynamics (ANGO) in Q2 2024, closing a stake of 1,712 shares — an estimated $10K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ANGO in Q2 2013 and held it in 44 quarters. The position peaked at $426K in Q3 2017. 139 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining AngioDynamics position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,712 AngioDynamics shares in Q2 2024, an estimated $10K.
Metropolitan Life Insurance Company (MetLife) first reported a position in AngioDynamics in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s AngioDynamics position peaked at $426K in Q3 2017.
139 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.